San Diego, CA, United States of America

Jui-Chen Lin

This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Arena Pharaceuticals, Inc., Vanderbilt University. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jui-Chen Lin. Retrieved from https://idiyas.com/inventor/jui-chen-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jui-Chen Lin: Innovator in Diabetes Treatment

Introduction

Jui-Chen Lin is a prominent inventor based in San Diego, California. She has made significant contributions to the field of diabetes treatment through her innovative research and patent work. Her dedication to improving health outcomes for individuals with diabetes is evident in her latest patent.

Latest Patents

Jui-Chen Lin holds a patent for "Systems, compositions and methods for treating diabetes." This patent provides methods for treatment that involve co-administering insulin and glucagon to a subject. It also includes co-formulations comprising both insulin and glucagon, showcasing her innovative approach to diabetes management.

Career Highlights

Lin is affiliated with Vanderbilt University, where she continues her research and development in the field of diabetes treatment. Her work is characterized by a commitment to advancing medical science and improving patient care.

Collaborations

Throughout her career, Jui-Chen Lin has collaborated with esteemed colleagues such as Alan Cherrington and David Maggs. These partnerships have further enhanced her research and contributed to the advancement of diabetes treatment methodologies.

Conclusion

Jui-Chen Lin is a trailblazer in the field of diabetes treatment, with a focus on innovative methods that combine insulin and glucagon. Her contributions through her patent and collaborations highlight her commitment to improving health outcomes for those affected by diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…